Obesity Is an Independent Predictor of Poor Survival in  Metastatic Breast Cancer: Retrospective Analysis of a Patient  Cohort Whose Treatment Included High-Dose  Chemotherapy and Autologous Stem Cell Support

<table class="table-group" width="800px"><tr class="fig-image" id="a"><td><img alt="523276.fig.001a" src="https://static.hindawi.com/articles/ijbc/volume-2011/523276/figures/523276.fig.001a.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(a) </b>Survival from initial diagnosis</td></tr></table></td></tr><tr class="fig-image" id="b"><td><img alt="523276.fig.001b" src="https://static.hindawi.com/articles/ijbc/volume-2011/523276/figures/523276.fig.001b.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(b) </b>Survival from diagnosis of metastasis</td></tr></table></td></tr></table>

<table>Overall survival and progression-free survival for all patients (<svg height="11.1625" id="M11" style="vertical-align:-0.27588pt" version="1.1" viewbox="0 0 42.912498 11.1625" width="42.912498" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,11.1625)">
<g transform="translate(72,-63.07)">
<text transform="matrix(1,0,0,-1,-71.95,63.4)">
<tspan style="font-size: 12.50px; " x="0" y="0">𝑛</tspan>
<tspan style="font-size: 12.50px; " x="9.6773224" y="0">=</tspan>
<tspan style="font-size: 12.50px; " x="21.71771" y="0">9</tspan>
<tspan style="font-size: 12.50px; " x="27.969212" y="0">6</tspan>
</text>
</g>
</g>
</svg>) from initial diagnosis (a) and diagnosis of metastasis (b). Survival was estimated by Kaplan-Meier method.</table>

International Journal of Breast Cancer

fig1

Figure 1

Figure 1: Obesity Is an Independent Predictor of Poor Survival in  Metastatic Breast Cancer: Retrospective Analysis of a Patient  Cohort Whose Treatment Included High-Dose  Chemotherapy and Autologous Stem Cell Support 

Figure 1 | Obesity Is an Independent Predictor of Poor Survival in  Metastatic Breast Cancer: Retrospective Analysis of a Patient  Cohort Whose Treatment Included High-Dose  Chemotherapy and Autologous Stem Cell Support 